Halozyme proposes offering of $500M convertible senior notes due 2027
February 23 2021 - 4:17PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Halozyme Therapeutics (NASDAQ:HALO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Halozyme Therapeutics (NASDAQ:HALO)
Historical Stock Chart
From Sep 2023 to Sep 2024